[Federal Register Volume 83, Number 73 (Monday, April 16, 2018)]
[Notices]
[Page 16360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07814]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--RFA-CE-18-004, Research to 
Evaluate Medication Management of Opioids and Benzodiazepines to 
Reduce Older Adult Falls.
    Dates: June 6, 2018 and June 7, 2018.
    Time: 9:00 a.m.-5:00 p.m., EDT.
    Place: DoubleTree by Hilton Hotel Atlanta--Buckhead, 3342 
Peachtree Road NE, Atlanta, GA 30326.
    Agenda: To review and evaluate grant applications.

FOR FURTHER INFORMATION CONTACT:  Mikel Walters, Ph.D., Scientific 
Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63, 
Atlanta, Georgia 30341, Telephone: (404) 639-0913; Email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-07814 Filed 4-13-18; 8:45 am]
 BILLING CODE 4163-18-P